期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

钙通道阻滞剂在认知障碍防治中的应用 被引量：3

Application of Calcium Channel Blockers for Prevention and Treatment of Cognitive Impairment
下载PDF
导出
摘要 认知障碍是一个具有重要医学和社会意义的问题,血管危险因素是其重要的病因。大量临床试验和汇总分析表明,钙通道阻滞剂不仅能治疗各种痴呆,还能预防急性缺血性卒中、高血压、蛛网膜下腔出血和脑外伤患者认知障碍的发生。 Cognitive impairment is an important medical and social issue with vascular risk factors as its cause. A great number of clinical trials and meta-analyses have demonstrated that calcium channel blockers can not only treat various type of dementias, but also prevent cognitive imprments following acute ischemic stroke, hypertension, subarachnoid hemorrhage, and brain trauma.
作者 张微微
机构地区 北京军区总医院神经内科
出处 《国外医学（脑血管疾病分册）》 2005年第9期686-688,共3页 Foreign Medical Sciences Cerebrovascular Diseases
关键词 钙通道阻滞剂 认知障碍 急性缺血性卒中 蛛网膜下腔出血 防治 血管危险因素 脑外伤患者 社会意义 汇总分析 临床试验 calcium channel blocker cognitive impairment
分类号 R749.2 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献11

  • 1黄觉斌,张振馨,洪霞,魏镜,温洪波,段蕾蕾,王清华,赵洁皓,吴继星,方友春.自然人群中老年人轻度认知障碍的随访研究[J].中华神经科杂志,2004,37(2):105-108. 被引量：25
  • 2Opez-ArrietaL, Birks J. Nimodipine for primary degenerative,mixed and vascular dementia. Cochrane Database Syst Rev, 2002,(3): CD000147.
  • 3Pantoni L, del Ser T, Soglian AG, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebocontrolled trial. Stroke, 2005, 36: 619-624.
  • 4沈树红,王少石,朱鑫璞,朱甬慧,邵薇娟.钙拮抗剂对血管性痴呆患者认知功能和脑血流及脑微循环的影响[J].中国临床康复,2005,9(13):44-45. 被引量：16
  • 5The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke, 1992, 23:3-8.
  • 6Sze KH, Sim TC, Wong E, et al. Effect of nimodipine on memory after cerebral infarction. Acta Neurol Scand, 1998, 97:386-392.
  • 7陈存国,金小红.尼莫同、刺五加联合治疗血管性痴呆疗效观察[J].临床医学,2004,24(11):14-15. 被引量：5
  • 8Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke, 2000,1250-1255.
  • 9Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet, 1998, 352:1347-1351.
  • 10Rinkel GJ, Feigin VL, Algra A, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev,2005, (3): CD000277.

二级参考文献29

  • 1郎森阳.血管性痴呆的诊断与鉴别[J].中国临床康复,2004,8(16):3143-3145. 被引量：18
  • 2王桂红.尼莫地平在中枢神经系统疾患中应用的药理学基础[J].国外医学（脑血管疾病分册）,1997,5(2):96-99. 被引量：111
  • 3Wallin A. Current definition and classification of dementia diseases. Acta Neurol Scand Suppl 1996; 168:39 - 44.
  • 4Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43 (2): 250 - 60.
  • 5Cockrell JR, Folstein MF. Mini-Mental State Examination(MMSE). Psychopharm Bull 1988; 24(4): 689 -92.
  • 6Morris JC. The Clinical Dementia Rating(CDR): current version and scoring rules. Neurology 1993:43 ( 11 ): 2412 - 4.
  • 7Lopez-Arrieta JM.Birks J Nimodipine for primary degenerative,mixed and vascular dementia.Cochrane Database Syst Rev 2002;3:CD000147.
  • 8Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology, 2002, 59:198-205.
  • 9Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment(an evidence-based review).Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2001,56:1133-1142
  • 10Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci biobehav Rev, 2000,24:365-374.

共引文献43

同被引文献70

引证文献3

二级引证文献61

国外医学（脑血管疾病分册）
2005年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部